Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sildenafil in Fetal Growth Retardation
NCT01107782Phase 3Unknown
- Sponsor
- Tehran University of Medical Sciences
- Start
- Jun 2008
- Primary completion
- Jun 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ASP-001 in fetal growth restriction (FGR), sponsored by Tehran University of Medical Sciences. Status: unknown.
02
Drugs
ASP-001
03
Conditions
fetal growth restriction (FGR)
Beyond the preview
Go deeper on NCT01107782.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01107782.